LifeGuide

Hide and Seek Led by Dr. Daria Hazuda, researchers tackle HIV latency with HDAC inhibitors by Chael Needle With all the talk around viral suppression, it may...

LifeGuide Therapeutic Vaccines May Change the Treatment Landscape for the Better by Jeannie Gibbs Clinical development of HIV therapeutic vaccine candidate, Vacc-4x, will continue after further...

Finding New Solutions Have a frank talk with your physician about a common complaint: diarrhea by John Francis Leonard When antiretroviral therapy (ART) was introduced to patients...

Hep Talk by Larry Buhl Two Agents New direct-acting antivirals cross a major hurdle                       The Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA)...

An antigen and antibody combo assay zeroes in on acute infection Treatment Horizons by Chael Needle The diagnosis of acute HIV infection, when the virus is...

At the 16th European AIDS Conference in Milan, Italy, on October 25, 2017, Janssen Pharmaceutica, NV announced the results of its Phase 3 AMBER...

The U.S. Food and Drug Administration (FDA) has approved pharmaceutical giant Merck’s Delstrigo and Pifeltro for the treatment of HIV-1 infection in adult patients...

The Strength of Women The Imbokodo Study launches in Southern Africa by Jeannie Wraight In Zulu, the word “Imbokodo” means “rock” and is part of a well-known...

Therapeutic Vaccine Research Toward a Functional Cure Shows Promise by Jeannie Wraight Until recently, therapeutic vaccines and immune-based therapies (IBTs) were all but shunned by the...

LifeGuide Planting Seeds An activist shares grassroots strategies for making HCV treatment available worldwide by Larry Buhl Hepatitis treatment advocates identify three significant barriers to eradicating hepatitis C...